BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28579008)

  • 21. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
    Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K
    Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary pulmonary synovial sarcoma: A reappraisal.
    Panigrahi MK; Pradhan G; Sahoo N; Mishra P; Patra S; Mohapatra PR
    J Cancer Res Ther; 2018; 14(3):481-489. PubMed ID: 29893303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.
    Stegmaier S; Leuschner I; Poremba C; Ladenstein R; Kazanowska B; Ljungman G; Scheer M; Blank B; Bielack S; Klingebiel T; Koscielniak E
    Pediatr Blood Cancer; 2017 Jan; 64(1):89-95. PubMed ID: 27621063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma.
    Storlazzi CT; Mertens F; Mandahl N; Gisselsson D; Isaksson M; Gustafson P; Domanski HA; Panagopoulos I
    Genes Chromosomes Cancer; 2003 Jun; 37(2):195-200. PubMed ID: 12696068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
    Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
    Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
    Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA
    Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China.
    Lan T; Chen H; Xiong B; Zhou T; Peng R; Chen M; Ye F; Yao J; He X; Wang Y; Zhang H
    Diagn Pathol; 2016 Jul; 11(1):62. PubMed ID: 27401493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.
    Fligman I; Lonardo F; Jhanwar SC; Gerald WL; Woodruff J; Ladanyi M
    Am J Pathol; 1995 Dec; 147(6):1592-9. PubMed ID: 7495284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
    Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
    Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1 and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: report of 25 cases from St. Jude Children's Research Hospital.
    Hill DA; Riedley SE; Patel AR; Shurtleff SA; Hyer J; Cain AM; Billups CA; Downing JR; Pappo AS
    Pediatr Dev Pathol; 2003; 6(1):24-34. PubMed ID: 12469233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group.
    Bégueret H; Galateau-Salle F; Guillou L; Chetaille B; Brambilla E; Vignaud JM; Terrier P; Groussard O; Coindre JM
    Am J Surg Pathol; 2005 Mar; 29(3):339-46. PubMed ID: 15725802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
    Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
    Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma.
    Fernebro J; Francis P; Edén P; Borg A; Panagopoulos I; Mertens F; Vallon-Christersson J; Akerman M; Rydholm A; Bauer HC; Mandahl N; Nilbert M
    Int J Cancer; 2006 Mar; 118(5):1165-72. PubMed ID: 16152617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mediastinal Synovial Sarcoma: Clinicopathologic Analysis of 21 Cases With Molecular Confirmation.
    Terra SBSP; Aesif SW; Maleszewski JJ; Folpe AL; Boland JM
    Am J Surg Pathol; 2018 Jun; 42(6):761-766. PubMed ID: 29543673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.
    Yoneda Y; Ito S; Kunisada T; Morimoto Y; Kanzaki H; Yoshida A; Shimizu K; Ozaki T; Ouchida M
    PLoS One; 2013; 8(10):e77564. PubMed ID: 24130893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases.
    Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ
    Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF Destruction.
    Li J; Mulvihill TS; Li L; Barrott JJ; Nelson ML; Wagner L; Lock IC; Pozner A; Lambert SL; Ozenberger BB; Ward MB; Grossmann AH; Liu T; Banito A; Cairns BR; Jones KB
    Cancer Discov; 2021 Oct; 11(10):2620-2637. PubMed ID: 34078620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
    Inagaki H; Nagasaka T; Otsuka T; Sugiura E; Nakashima N; Eimoto T
    Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
    Wei Y; Wang J; Zhu X; Shi D; Hisaoka M; Hashimoto H
    Chin Med J (Engl); 2002 Jul; 115(7):1043-7. PubMed ID: 12150740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.